Cell Death and Disease, 2022 · DOI: 10.1038/s41419-022-05001-6 · Published: June 7, 2022
Spinal and bulbar muscular atrophy (SBMA) is a hereditary neurodegenerative disease caused by expansions of CAG repeats in the androgen receptor (AR) gene. Androgen-dependent nuclear accumulation of pathogenic AR protein causes degeneration of lower motor neurons, leading to progressive muscle weakness and atrophy. The study found upregulation of Mid1, a microtubule-associated RNA binding protein, in motor neurons of SBMA mice. Mid1 facilitates the translation of CAG-expanded mRNAs, including the pathogenic AR protein. Using spinal cord slice cultures from SBMA mouse fetuses, the study showed that Mid1 overexpression exacerbated androgen-dependent impairment of axonal regeneration, while Mid1 knockdown ameliorated it, suggesting Mid1 contributes to motor neuron vulnerability in SBMA.
Mid1 represents a potential therapeutic target for SBMA. Inhibiting Mid1 could reduce the levels of pathogenic AR protein and alleviate motor neuron dysfunction.
Upregulation of Mid1 in motor neurons could serve as a diagnostic marker for SBMA, aiding in early detection and intervention.
The findings support the development of drugs targeting the Mid1-AR interaction to prevent or slow down the progression of SBMA.